Effect of Folic Acid Supplementation on Risk of Cardiovascular Diseases: A Meta-analysis of Randomized Controlled Trials
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
CONTEXT: Epidemiologic studies have suggested that folate intake decreases risk of cardiovascular diseases. However, the results of randomized controlled trials on dietary supplementation with folic acid to date have been inconsistent. OBJECTIVE: To evaluate the effects of folic acid supplementation on risk of cardiovascular diseases and all-cause mortality in randomized controlled trials among persons with preexisting cardiovascular or renal disease. DATA SOURCES: Studies were retrieved by searching MEDLINE (January 1966-July 2006) using the Medical Subject Headings cardiovascular disease, coronary disease, coronary thrombosis, myocardial ischemia, coronary stenosis, coronary restenosis, cerebrovascular accident, randomized controlled trial, clinical trials, homofolic acid, and folic acid, and the text words folic acid and folate. Bibliographies of all retrieved articles were also searched, and experts in the field were contacted. STUDY SELECTION: From 165 relevant retrieved reports, 12 randomized controlled trials compared folic acid supplementation with either placebo or usual care for a minimum duration of 6 months and with clinical cardiovascular disease events reported as an end point. DATA EXTRACTION: Data on study design, characteristics of participants, changes in homocysteine levels, and cardiovascular disease outcomes were independently abstracted by 2 investigators using a standardized protocol. DATA SYNTHESIS: Studies including data from 16 958 participants with preexisting vascular disease were analyzed using a random-effects model. The overall relative risks (95% confidence intervals) of outcomes for patients treated with folic acid supplementation compared with controls were 0.95 (0.88-1.03) for cardiovascular diseases, 1.04 (0.92-1.17) for coronary heart disease, 0.86 (0.71-1.04) for stroke, and 0.96 (0.88-1.04) for all-cause mortality. The relative risk was consistent among participants with preexisting cardiovascular or renal disease. CONCLUSIONS: Folic acid supplementation has not been shown to reduce risk of cardiovascular diseases or all-cause mortality among participants with prior history of vascular disease. Several ongoing trials with large sample sizes might provide a definitive answer to this important clinical and public health question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 2,972
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
Ks, M. (1969) · PubMed Central · Cited by 1,803
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060900 · Cited by 1,729
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., & Hess, O. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011364 · Cited by 532
Homocystinuria: An Enzymatic Defect
Mudd, S. H., Finkelstein, J. D., Irreverre, F., & Laster, L. (1964) · Science · doi:10.1126/science.143.3613.1443 · Cited by 513
Schnyder, G., Roffi, M., Flammer, Y., Pin, R., & Hess, O. M. (2002) · JAMA · doi:10.1001/jama.288.8.973 · Cited by 379
Wald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J., & Scott, J. M. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.862 · Cited by 369
Folate Therapy and In-Stent Restenosis after Coronary Stenting
Lange, H., Suryapranata, H., De Luca, G., Börner, C., Dille, J., Kallmayer, K., Pasalary, M. N., Scherer, E., & Dambrink, J.-H. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032845 · Cited by 336
Randomized Trial of Folic Acid for Prevention of Cardiovascular Events in End-Stage Renal Disease
Wrone, E. M., Hornberger, J. M., Zehnder, J. L., McCann, L. M., Coplon, N. S., & Fortmann, S. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000110181.64655.6c · Cited by 249
Zoungas, S., McGrath, B. P., Branley, P., Kerr, P. G., Muske, C., Wolfe, R., Atkins, R. C., Nicholls, K., Fraenkel, M., Hutchison, B. G., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.064 · Cited by 241
High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
Bostom, A. G., Shemin, D., Lapane, K. L., Hume, A. L., Yoburn, D., Nadeau, M. R., Bendich, A., Selhub, J., & Rosenberg, I. H. (1996) · Kidney International · doi:10.1038/ki.1996.19 · Cited by 240
Vitamins as Homocysteine-Lowering Agents
Brattström, L. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.suppl_4.1276s · Cited by 175
B-Vitamin Treatment Trialists' Collaboration (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.025 · Cited by 166
Bazzano, L. A., He, J., Ogden, L. G., Loria, C., Vupputuri, S., Myers, L., & Whelton, P. K. (2002) · Stroke · doi:10.1161/01.str.0000014607.90464.88 · Cited by 159
Self-citationJacob, R. A., Wu, M.-M., Henning, S. M., & Swendseid, M. E. (1994) · Journal of Nutrition · doi:10.1093/jn/124.7.1072 · Cited by 150
(2002) · Cerebrovascular Diseases · doi:10.1159/000047761 · Cited by 137
Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients
Righetti, M., Serbelloni, P., Milani, S., & Ferrario, G. (2006) · Blood Purification · doi:10.1159/000093680 · Cited by 115
Bostom, A. G., Selhub, J., Jacques, P. F., & Rosenberg, I. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-2-200107170-00014 · Cited by 101
Guelpen, B. R. V., Hultdin, J., Johansson, I., Stegmayr, B., Hallmans, G., Nilsson, T., Weinehall, L., Witthöft, C. M., Palmqvist, R., & Winkvist, A. (2005) · Stroke · doi:10.1161/01.str.0000169934.96354.3a · Cited by 94
MacMahon, M., Kirkpatrick, C. A., Cummings, C. E., Clayton, A., Robinson, P. J., Tomiak, R. H. H., Liu, M., Kush, D., & Tobert, J. A. (2000) · PubMed · Cited by 91
Liem, A. H., van Boven, A. J., Veeger, N. J. G. M., Withagen, A. J. A. M., de Medina, R. M. R., Tijssen, J. G. P., & van Veldhuisen, D. J. (2003) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.02.001 · Cited by 76
Folate supplementation and cardiovascular disease
Smith, G. D., & Ebrahim, S. B. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67676-3 · Cited by 66
Righetti, M., Ferrario, G. M., Milani, S., Serbelloni, P., Rosa, L. L., Uccellini, M., & Sessa, A. (2003) · PubMed · Cited by 65
Secondary prevention with folic acid: results of the Goes extension study: Figure 1
Liem, A., Reynierse-Buitenwerf, G. H., Zwinderman, A. H., Jukema, J. W., & van Veldhuisen, D. J. (2005) · Heart · doi:10.1136/hrt.2004.035030 · Cited by 64
Bostom, A. G., Carpenter, M. A., Kusek, J. W., Hunsicker, L. G., Pfeffer, M. A., Levey, A. S., Jacques, P. F., & McKenney, J. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.03.004 · Cited by 61
Bleie, Ø., Refsum, H., Ueland, P. M., Vollset, S. E., Guttormsen, A. B., Nexø, E., Schneede, J., Nordrehaug, J. E., & Nygard, O. K. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.641 · Cited by 50
The Women's Antioxidant Cardiovascular Study: Design and Baseline Characteristics of Participants
Bassuk, S. S., Albert, C. M., Cook, N. R., Zaharris, E., MacFadyen, J. G., Danielson, E., Van Denburgh, M., Buring, J. E., & Manson, J. E. (2004) · Journal of Women's Health · doi:10.1089/154099904322836519 · Cited by 48
Galan, P., de Bree, A., Mennen, L. I., de Courcy, G. P., Preziozi, P., Bertrais, S., Castetbon, K., & Herçberg, S. (2003) · PubMed · Cited by 48
Mason, P. J., Manson, J. E., Sesso, H. D., Albert, C. M., Chown, M. J., Cook, N. R., Greenland, P., Ridker, P. M., & Glynn, R. J. (2004) · Circulation · doi:10.1161/01.cir.0000124488.06377.77 · Cited by 43
Jamison, R. L., Hartigan, P. M., Gaziano, J. M., Fortmann, S. P., Goldfarb, D. S., Haroldson, J. A., Kaufman, J. S., Lavori, P. W., McCully, K. S., & Robinson, K. (2004) · Clinical Trials · doi:10.1191/1740774504cn038oa · Cited by 21
Cited by
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
One-Carbon Metabolism in Health and Disease
Ducker, G. S., & Rabinowitz, J. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.009 · Cited by 2,239
“…lowering homocysteine levels, folate and cobalamin supplementation do not reduce the incidence of cardiovascular events in the general population, arguing against high homocysteine levels directly causing cardiovascular disease (Bazzano et al., 2006; Lonn et al., 2006; Zhou et al., 2011).”
BackgroundFihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Metadata
- Authors
- Bazzano, L. A., Reynolds, K., Holder, K. N., & He, J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-12-13
- Volume
- 296
- Issue
- 22
- Pages
- 2720
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2021836023
- Cited by
- 426
- References
- 44
- FWCI
- 32.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.